Schering-Plough and PTC Therapeutics Announce Collaboration for ... (Chronic Hepatitis C)

Schering-Plough and PTC Therapeutics Announce Collaboration for ...
PR Newswire UK (press release), UK - 4 hours ago... Chronic hepatitis C is estimated to affect more than 10 million people in major world markets, including in Canada, Europe and the United States. ...

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety ...
Medical News Today (press release), UK - Feb 22, 2006... planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin(TM) Anti-Viral in the treatment of chronic hepatitis C virus infection ...

New hope for Hepatitis C patients
Trade Arabia, Bahrain - Feb 25, 2006... the results of a study on the efficacy and tolerability of Pegasys with or without Ribavirin in Thalassaemia Major patients with chronic Hepatitis C. The study ...

Hepatitis C Treatment for People With Severe Mental Illness
Psychosomatics (subscription) - Feb 28, 2006... Chander G, Sulkowski MS, Jenckes MW, et al: Treatment of chronic hepatitis C: a systematic review. Hepatology 2002; 36(suppl1):S135-144. ...

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - Mar 15, 2006... Chronic hepatitis C (CHC) is currently managed through combination therapy consisting of pegylated interferon (pegIFN) and ribavirin (RBV), marketed by Roche ...